SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3499Note that this is not (necessarily) a zero/zero deal as discussed elsewhere. TheBiomaven6/5/2003
3498<i>Don't you think that they have the buyer(s) more or less lined up bnigel bates6/5/2003
3497>>Very nice for CEPH if they can sell it, but what kind of idiot would be Icebrg6/5/2003
3496<i>The notes will be subordinate to existing <b>and future</b>nigel bates6/5/2003
3495Cephalon Announces Proposed Convertible Subordinated Notes Offering Thursday JunIcebrg6/5/2003
3494chunka chunka chunka change. (eom)scaram(o)uche6/4/2003
3493LONDON, June 4 (Reuters) - A leading Anglo-American fund manager said on Wednesdnigel bates6/4/2003
3492PARS. Sweet deal if tbi works. Pharmos Raises $8 Million in Private Equity Trakeokalani'nui6/2/2003
3491Positive Results from Phase III Avastin Study in Metastatic Colorectal Cancer Prscaram(o)uche6/1/2003
3490Phase 3 Data Suggest Palifermin Significantly Reduces the Duration and Incidencescaram(o)uche6/1/2003
3489version 3...... Companies Under Coverage Biomarin Pharmaceutical, Inc. (BMRN, Bscaram(o)uche5/31/2003
3488Thank for finding that! Look at the history of SyStemix. Novartis is doing somscaram(o)uche5/29/2003
3487One to watch. But I wonder how the anonymous $12m donor to SU's stem cell pkeokalani'nui5/29/2003
3486>>WARREN, N.J., May 28 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdtuck5/28/2003
3485European Commission Approves FUZEON(TM), First HIV Fusion Inhibitor, for Use Agascaram(o)uche5/27/2003
3484ICOS Corporation Files Shelf Registration Statement Tuesday May 27, 4:50 pm ET Icebrg5/27/2003
3483I lied. $6. Wow. (eom)scaram(o)uche5/23/2003
3482$5. Wow. Jerry...... last post rubbing my nose in this. Sure wish that I&#scaram(o)uche5/22/2003
3481SAN DIEGO--(BUSINESS WIRE)--May 22, 2003--Santarus, Inc., a specialty pharmaceutnigel bates5/22/2003
3480Phase III Trial of Avastin Plus Chemotherapy Markedly Extends Survival of Metastscaram(o)uche5/19/2003
3479"Encysive" <i>Our new identity better reflects our optimism, stnigel bates5/18/2003
3478barf....... Texas Biotechnology Announces Company Name Change to Encysive Pharmscaram(o)uche5/16/2003
3477Gilead Raises Outlook On '03 Viread Sales To $475M-$500M Thursday May 15, 4:scaram(o)uche5/15/2003
3476Xolair gets Advisory Committee nod..... Message 18948665scaram(o)uche5/15/2003
3475wow...... fulcrumgp.com send him some big floppy shoes and a big red nose.scaram(o)uche5/15/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News